Position in LENZ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$362,532
-$16,014,140 QoQ
Shares Held
39,621
-96.1% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 86.26738345826708.ToString("F0")%
Shared 0.ToString("F0")%
None 13.73261654173292.ToString("F0")%
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. LENZ ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,206,618 | $305,117,340 |
All Filings in LENZ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $362,532 | 39,621 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,376,672 | 1,023,542 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,697,681 | 251,131 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $437,686 | 14,933 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,892,404 | 306,978 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,758,767 | 822,957 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,650,499 | 448,631 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||